Prostate cancer screening is a way to test for prostate cancer in men who do not have symptoms of the disease. The two main tests used for prostate cancer screening? These are the prostate-specific antigen (PSA) test and the digital rectal exam (DRE).

The PSA test measures the level of PSA, a protein produced by the prostate gland, in the blood. Elevated levels of PSA may be a sign of this disease. Other conditions such as an enlarged prostate or a prostate infection can also cause high PSA levels.

The DRE is a physical exam in which the doctor feels the prostate gland to check for any abnormalities.

There is ongoing debate about the effectiveness of getting screened. Some studies have suggested that prostate cancer screening can help reduce the risk of dying from this type of disease. However, other studies have found no benefit.

The American Cancer Society recommends that men discuss the potential benefits and risks of prostate cancer screening with their healthcare provider. They should start doing so beginning at age 50 for most men. Men at high risk of this malicious cancer (such as men with a family history of the disease) should get screened at age 45.

Decisions about whether to undergo screening should be based on a man’s individual risk factors and his preferences. Each individual should take into account the potential benefits and risks of the tests.

Are you seeking health insurance to cover your upcoming prostate screening? Chat with a licensed agent at 855-522-2201 to learn about all the coverage options available to you. Healthedly is here to help!